Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe hemorrhage

M J R Desborough^{1

2}, C A T Hildyard², S J Stanworth³

Affiliations

¹ Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
² Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
³ NHS Blood and Transplant, Oxford, UK.

Free article

Comment

M J R Desborough et al. J Thromb Haemost. 2018 Jun.

Free article

. 2018 Jun;16(6):1025-1027.

doi: 10.1111/jth.14010. Epub 2018 May 24.

M J R Desborough^{1

2}, C A T Hildyard², S J Stanworth³

¹ Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
² Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
³ NHS Blood and Transplant, Oxford, UK.

No abstract available

Comment on

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients.
Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration. Gayet-Ageron A, et al. Lancet. 2018 Jan 13;391(10116):125-132. doi: 10.1016/S0140-6736(17)32455-8. Epub 2017 Nov 7. Lancet. 2018. PMID: 29126600 Free PMC article.